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3,3’-Diindolylmethane (DIM) and its synthetic halogenated derivatives 4,4’-Br2- and 7,7’-
Cl2DIM (ring-DIMs) have recently been shown to induce protective autophagy in human prostate 
cancer cells. The mechanisms by which DIM and ring-DIMs induce autophagy have not been 
elucidated. As DIM is a mitochondrial ATP-synthase inhibitor, we hypothesized that DIM and 
ring-DIMs induce autophagy via alteration of intracellular AMP/ATP ratios and activation of 
AMPK signaling in prostate cancer cells. We found that DIM and ring-DIMs induced autophagy 
was accompanied by increased autophagic vacuole formation and conversion of LC3BI to 
LC3BII in LNCaP and C42B human prostate cancer cells. DIM and ring-DIMs also induced 
AMP-activated protein kinase (AMPK), ULK-1 (unc-51-like autophagy activating kinase 1; 
Atg1) and acetyl-CoA carboxylase (ACC) phosphorylation in a time-dependent manner. DIM 
and the ring-DIMs time-dependently induced the oncogenic protein astrocyte-elevated gene 1 
(AEG-1) in LNCaP and C42B cells. Downregulation of AEG-1 or AMPK inhibited DIM- and 
ring-DIM-induced autophagy. Pretreatment with ULK1 inhibitor MRT 67307 or siRNAs 
targeting either AEG-1 or AMPK potentiated the cytotoxicity of DIM and ring-DIMs. 
Interestingly, downregulation of AEG-1 induced senescence in cells treated with overtly 
cytotoxic concentrations of DIM or ring-DIMs and inhibited the onset of apoptosis in response to 
these compounds. In summary, we have identified a novel mechanism for DIM- and ring-DIM-
induced protective autophagy, via induction of AEG-1 and subsequent activation of AMPK. Our 
findings could facilitate the development of novel drug therapies for prostate cancer that include 















Prostate cancer is a major health problem worldwide, ranking as the second most common cancer 
in males [1] and the third leading cause of cancer-related deaths among American and Canadian 
men [2]. Treatment with drugs targeting androgen receptor signaling is the main therapy for 
early-stage androgen-dependent (AD) prostate cancer [3]. Unfortunately, many patients with AD 
prostate cancer will progress to an androgen-independent (AI) phenotype which is harder to treat 
and often fatal [4, 5]. Diindolylmethane (DIM) is a promising anticancer agent derived from the 
ingestion of Brassica plants (cabbage, broccoli, etc.) [6]. We have shown that several di-
halogenated analogs of DIM (ring-DIMs) have anti-androgenic effects in human AD LNCaP 
prostate cancer cells [7] and induce apoptosis and necrosis in LNCaP and human AI PC-3 
prostate cancer cells with greater potencies than DIM [8]. More recently, we have shown that 
DIM and ring-DIMs induce ER stress, mitochondrial dysfunction and autophagy in prostate 
cancer cells [9]. Autophagy is a self-digestion process activated by cellular stress, in which 
dysfunctional organelles and protein aggregates are sequestered in double-membraned 
vesicles[10], and then transported to lysosomes for proteolytic degradation and recycling to 
maintain cellular homeostasis [11]. 
Autophagy plays an important role in cancer cell progression; its induction in response to stresses 
following chemotherapy may promote cancer cell survival. However, excessive autophagy could 
activate a cell death mechanism known as cytotoxic autophagy, which is different from 
programmed cell death (apoptosis) [12, 13]. Uncontrolled growth of cancer cells is due to the 
inactivation of cell death pathways, such as apoptosis, and stimulation of cell survival pathways 
[14]. Thus, the dysregulation of autophagic machinery in cancer cells, leading to imbalances in 













tumor progression or regression. Various Atg (autophagy-related) proteins are involved in 
initiation and regulation of autophagy [15].The conversion of LC3B (Atg3) from its diffuse 
LC3BI form into the punctuated LC3BII, which associates with the autophagosome [16], is used 
as a classic marker of autophagy. AMP-activated protein kinase (AMPK) regulates autophagy via 
phosphorylation of the autophagy-initiating protein ULK1 (Atg1) [17]. The oncogenic protein, 
astrocyte elevated gene-1 (AEG-1), also known as metadherin (MTDH) or protein LYRIC, is 
overexpressed in various cancer including that of the prostate [18, 19], where it acts as a mediator 
of AMPK activity and autophagy in response to cellular metabolic stress [20, 21]. AEG-1 
contributes to chemoresistance in hepatocellular carcinoma (HCC) cells [22] and promotes 
hepato-carcinogenisis through inhibition of senescence in transgenic mice that overexpress 
hepatocyte-specific AEG-1 [23].  
Although DIM is known to be a mitochondrial ATP synthase inhibitor [24] that alters AMP/ATP 
ratios leading to activation of AMPK [25], the exact mechanism(s) of DIM-induced protective 
autophagy has not been elucidated. Previous studies have shown that AEG-1 induces protective 
autophagy via activation of AMPK [21]. Therefore, we wished to determine the possible 
involvement of AEG-1 in AMPK activation as well as DIM- and ring-DIM-mediated induction 
of autophagy. 
2. MATERIALS AND METHODS 
2.1. Cell culture and treatment 
LNCaP androgen receptor-(AR)-positive and AD human prostate cancer cells were purchased 
from the American Type Culture Collection (Manassas, VA); LNCaP C4-2B (C42B) AR-positive 
and AI human prostate cancer cells were purchased from the MD Anderson Cancer Centre 













supplemented with 10% FBS, 1% penicillin/streptomycin (Life Technologies, Gaithersburg, 
MD) at 37°C and 5% CO2. Ring-DIMs were synthesized in our laboratories as previously 
described [8]. 
For cell treatments, LNCaP and C42B were seeded in 24-well CellBind culture plates (Corning 
Inc., Corning, NY) at a density of 1.5 x 10
5
 cells/well in RPMI 1640 supplemented with 2% 
dextran-coated charcoal-stripped FBS (Hyclone, Logan, UT); LNCaP cell medium was 
supplemented with 0.1 nM dihyrotestosterone (DHT; Steraloids Inc., Newport, RI). Cells were 
then treated with either DIM, ring-DIMs, or DMSO vehicle control (0.1% or 0.2% in the case of 
co-exposures). The ULK1 inhibitor MRT 67307 (Sigma-Aldrich, St-Louis, MO) was added to 
cell cultures four hours prior to treatment. 
2.2. Cell death assay  
For cell death measurements, LNCaP and C42B cells were treated with DIM, ring-DIMs, or 
vehicle control (DMSO). After 24 h of exposure, Hoechst 33342 (Sigma-Aldrich) and propidium 
iodide (PI; Invitrogen, Carlsbad, CA) stains were both added to each well at a concentration of 1 
µg/ml for 15 min at 37
o
C to detect apoptotic and necrotic (or late-apoptotic) cell death, 
respectively. Hoechst- and PI-positive cells were counted under a Nikon Eclipse (TE-2000U) 
inverted fluorescence microscope at 20x magnification using filter cubes with excitation 
wavelengths of 330-380 and 532-587 nm, respectively. Intact (viable) cells were counted as 
exhibiting neither Hoechst- (chromatin condensation/fragmentation) nor PI (cell membrane 
disintegration) staining. Subtoxic concentrations used for cell death analysis were as follows: 10 
µM for DIM, 5 µM for both 4,4'-Br2DIM and 7,7'-Cl2DIM in LNCaP cells; then 20 µM for DIM, 
10 µM for both 4,4'-Br2DIM and 7,7'-Cl2DIM in C42B cells. On the other hand, toxic 













Br2DIM and 7,7'-Cl2DIM in LNCaP cells; then, 30 µM for DIM, 15 µM for 4,4'-Br2DIM and 20 
µM 7,7'-Cl2DIM in C42B cells. At least 100 cells per treatment were examined. 
2.3 Cell Proliferation assay 
The effect of AEG-1 siRNA on cell proliferation of LNCap and C42B cells treated with DIM was 
determined using a WST-1 kit (Roche, Basel, Switzerland) which measures mitochondrial reductase 
activity of viable cells. LNCaP and primary C42B cells were plated in 96-well CellBind plates p 
(Corning Inc.) at a density of 1 x 10
3
 cells/well  in their appropriate culture medium for 24 h. Cells 
were then incubated with WST-1 substrate for 2 h and the formation of formezan was then measured using 
the absorbance at 440 nm with SpectraMax M5 spectrophotometer (Molecular Devices, Sunnyvale, 
California).  
2.4. Autophagic vacuole detection 
Autophagic vacuoles were measured using a Cyto-ID Autophagy detection kit (Enzo Life 
Sciences, Farmingdale, NY) according to the manufacturer’s protocol. Cells were cultured in 24 
well plates and treated with DIM or ring-DIMs for 24 h. Cells were washed with 1X assay buffer, 
then stained with CYTO-ID green detection reagent. Plates were protected from light and 
incubated for 30 minutes at 37°C.  
Cells were counterstained with Hoechst 33342 and the number of autophagic vacuoles per cell 
were counted in vehicle control (DMSO), DIM- and ring-DIM-treated cells under a Nikon 
Eclipse inverted fluorescence microscope. At least 50 cells per treatment were counted. 
2.5. Gene silencing with small interfering RNA (siRNA) 
LNCaP and C42B cells underwent reverse transfection with SMARTpool siRNA 
oligonucleotides (a mixture of 4 siRNA; Dharmacon, Lafayette, CO) targeting either AMPK or 













reverse transfection of cells in serum free Opti-MEM medium (Life Technologies) according to 
the manufacturer's protocol.  
2.6. Immunoblotting 
Cells were treated with DIM, ring-DIMs or DMSO in 6-well CellBind culture plates (Corning 
Inc.) at a density of 7.5 x 10
5
 cells/well. Cells were harvested using RIPA buffer (Pierce 
Biotechnologies, Rockford, IL) containing protease inhibitor cocktail and Halt phosphatase 
inhibitor (ThermoFisher, Waltham, MA). Protein concentrations were measured in cell lysates 
using a Pierce BCA protein assay kit (ThermoFisher). Twenty-five microgram aliquots of protein 
underwent electrophoresis on 10% sodium dodecyl sulfate-polyacrylamide gels and were then 
transferred to polyvinylidene difluoride (PVDF) membranes using a Trans-Blot Turbo Transfer 
System (Bio-Rad, Mississauga, ON). Rabbit primary antibodies for phospho-AMPK (T172), 
AMPK (23A3), phospho- acetyl-CoA carboxylase (pACC) (S79), ACC (C83B10), phospho-
UlK1 (D1H4) and mouse primary antibodies for AEG-1 (2F11C3) and β-actin (8H10D10) were 
purchased from Cell Signaling Technology (Danvers, MA). LC3B (L7543) rabbit primary 
antibody was purchased from Sigma-Aldrich. PVDF membranes were incubated with 1:1000 
dilutions of the primary antibodies overnight (4°C) in a shaking rotator. Membranes were washed 
three times with PBS and then incubated with a 1:5000 dilution of either goat anti-rabbit or goat 
anti-mouse horse radish peroxidase-conjugated secondary antibodies (Millipore, Billerica, MA) 
for 1 h at room temperature. Washing steps were repeated before adding clarity Western ECL 
substrate (Bio-Rad) for 5 min, after which the membranes were digitally photographed using a 
ChemiDoc MP Gel Doc system (Bio-Rad).  
2.7. Senescence assay 
LNCaP and C42B cells were cultured in their respective media in 6-well CellBind culture plates 
(Corning Inc.) at a density of 7.5 x 10
5













senescent cells were detected using a Senescence β-galactosidase staining kit (Cell Signaling) 
according to the manufacturer's instructions. Cells were cultured in 6-well plates and treated with DIM 
or ring-DIMs for 24 h. Cells were washed with 1X PBS, then fixed with 1X Fixative Solution. Cells were 
then washed with 1X PBS and stained with β-galactosidase staining solution. Plates were incubated at 
37°C overnight in a non-humidified incubator. Cells positive for β-galactosidase activity were 
counted by light microscopy under 100 X magnification in at least triplicate using different cell 
passages for each treatment. At least 50 cells per treatment were counted. 
2.8. Electron microscope analysis 
C42B cells were cultured in RPMI medium supplemented with 2% dextran-coated charcoal-
stripped FBS and seeded in 6-well CellBind culture plates (Corning Inc.) at a density 7.5 x 10
5
 
cells/well. Cells were treated with DIM or ring-DIMs for 8 h and then fixed using 2.5% 
glutaraldehyde in 0.1 M phosphate buffer at pH 7.2 for 15 min. Cells were scraped with a rubber 
policeman, transferred to 1.5 ml tubes and centrifuged for 3 min at 1200 rpm. The cells were 
washed 3 times for 15 min with 3% sucrose in 0.1 M cacodylate buffer. Cells were fixed with 
freshly prepared 1.3 % (w/v) osmium tetroxide in collidine buffer for 1-2 hours. Fixed cells were 
dehydrated by successive passage through 25, 50, 75, 95 and 100 % solutions of acetone in water 
(15-30 minutes each), then embedded in SPURR resin mixtures (Mecalab, Montreal, QC). The 
block containing fixed cells were cut and encapsulated in mold filled with SPURR resin.  
Ultrathin sections were prepared with an ultramicrotome (LKB, Sollentuna, Sweden) and placed 
onto copper grids. After staining with uranyl acetate and lead citrate, sections were examined 
using a Hitachi H-7100 transmission electron microscope. 













All experiments were performed at least 3 times independently using different cell passages. 
Treatments were performed in at least triplicate per experiment. Data are presented as mean ± 
SEM. Statistically significant differences (p < 0.05) between groups were determined using a 
one-way analysis of variance (ANOVA) followed by Dunnett’s post-hoc test to correct for 
multiple comparisons to vehicle control. All data were analyzed using GraphPad Prism (version 















3.1. DIM and ring-DIMs induce the formation of autophagic vacuoles in prostate cancer 
cells 
An 8-h treatment of androgen-sensitive LNCaP and androgen-insensitive C42B cells with DIM, 
4,4'-Br2DIM and 7,7'-Cl2DIM significantly increased the formation of autophagic vacuoles 
(Figure 1A-D). The concentrations used in these experiments were based on our previous studies 
on DIM- and ring-DIM-mediated induction of protective autophagy in the same prostate cancer 
cells [8, 9]. We also confirmed the formation of autophagosomes by transmission electron 
microscopy after exposure of C42B cells to DIM and the ring-DIMs for 8 h (Figure 1E).  
3.2. DIM and ring-DIMs induce autophagy via activation of AMPK signaling 
To investigate the mechanism of DIM- and ring-DIM-mediated autophagy, we determined their 
effects on AMPK signaling. DIM and ring-DIMs significantly increased the conversion of LC3BI 
to LC3BII (LC3B-II/I ratio) in LNCaP and C42B cells (Figure 2A, B, S2B, S3B). In LNCaP 
cells, a time-dependent increase of AMPK phosphorylation by 4,4'-Br2DIM was observed, 
whereas DIM significantly induced phosphorylation of AMPK only after treatment for 1 and 4 h, 
with levels decreasing after 8 h of exposure; however,  7,7'-Cl2DIM treatment didn’t change the 
levels of AMPK phosphorylation (Figure 2A, S2A). DIM and ring-DIMs significantly and time 
dependently increased AMPK phosphorylation in C42B cells at all time-points (Figure 2B, S3 
A). Activation of MPK signaling was confirmed in both cell lines by assessing the 
phosphorylation of its substrate acetyl-CoA carboxylase, ACC (Figure 2A, B, S2A, S3A). Next, 
we assessed whether the stimulation of AMPK activity resulted in an increased autophagic 
response by activating the autophagy initiator ULK1. We found that DIM and the ring-DIMs 













B, S2B, S3B). Pretreatment of cells with an ULK1 inhibitor (MRT67307, 10 µM) significantly 
sensitized LNCaP and C42B cells to cell death in the presence of sub-toxic concentrations of 
DIM or ring-DIMs (Figure 2C, D).  
To confirm the role of AMPK signaling in the autophagy induced by DIM and the ring-DIMs, 
siRNA was used to inhibit AMPK gene expression. The increased conversion of LC3BI to 
LC3BII (LC3BII/I ratio) after a 24-h exposure of LNCaP to DIM or ring-DIMs and C42B cells to 
ring-DIMs was inhibited when cells were pretreated with AMPK-selective siRNA, while 
pretreatment of C42B cells exposed to DIM with AMPK siRNA didn’t affect LC3BII/I ratio 
(Figure 3A, B, C, D). The siRNA-mediated inhibition of AMPK expression sensitized LNCaP 
and C42B cells to the cytotoxicity of normally sub-toxic concentrations of DIM and ring-DIMs 
(Figure 3E, F). 
3.3. DIM and ring-DIMs promote autophagy via induction of AEG-1 
Since AEG-1 is an upstream regulator of AMPK [20, 21], we therefore investigated the effect of    
DIM and ring-DIMs on induction of AEG-1 and AMPK-mediated autophagy. DIM induced 
AEG-1 expression in a time-dependent manner in both LNCaP and C42B cells (Figure 4A, B, C, 
D). 4,4'-Br2DIM , and 7,7'-Cl2DIM time dependently increased AEG-1 levels in LNCaP and 
C42B cells after a 1- and 4-h exposure, an effect that was no longer seen after 8 h. (Figure 4A, B, 
C, D). Pretreatment of LNCaP and C42B cells with AEG-1-selective siRNA inhibited DIM- and 
ring-DIM-mediated LC3BI-to-LC3BII conversion (Figure 5A, B, C, D) and sensitized LNCaP 
and C42B cells to the cytotoxicity of normally sub-toxic concentrations of DIM or ring-DIMs 
(Figure 5E, F). To know whether AEG-1 acts upstream or downstream of AMPK, ACC 













C42B cells exposed to DIM or ring-DIMs in the presence or absence of pretreatment with AEG-1 
siRNA. Our results showed that inhibition of AEG-1 using selective siRNA reduced AMPK 
activation based on the phosphorylation of ACC (Fig 5A, B, C, D), which indicates that AEG-1 is 
an upstream regulator of AMPK. 
3.4. Downregulation of AEG-1 induces senescence in LNCaP and C42B cells 
To further explore the role of AEG-1 in DIM- and ring-DIM-mediated cytotoxicity, we assessed 
the effect of AEG-1 downregulation in LNCaP and C42B cells on their response to cytotoxic 
concentrations of DIM and ring-DIMs. Interestingly, siRNA-mediated silencing of AEG-1 
expression protected LNCaP and C42B cells against the toxicity of DIM and ring-DIMs (Fig 6A, 
B). AEG-1 may affect multiple pathways related to cancer progression; hence, we investigated 
the effect of AEG-1 downregulation on cellular senescence. Pretreatment with AEG-1-selective 
siRNA promoted senescence as indicated by increased β-galactosidase activity in LNCaP (Fig 
6C, E) and C42B (Fig 6D, F) cells treated with toxic concentrations of DIM and ring-DIMs. 
Induction of senescence was also confirmed by investing the effect of AEG-1 siRNA on cell 
proliferation of LNCaP and C42B cells treated with DIM. Our results showed a significant 
inhibition of cell proliferation in LNCaP and C42B cells pretreated with AEG-1 siRNA and then 
treated with DIM compared to DMSO control cells. 
4. DISCUSSION 
Our current findings demonstrate that DIM and ring-DIMs activate the AMPK signaling in 
LNCaP and C42B cells by increasing AMPK-, ACC-(a substrate uniquely phosphorylated by 
AMPK) and ULK1 phosphorylation in a time-dependent manner (Fig 2). Chen and coworkers 













can activate AMPK signaling as early as 3 h after exposure [25]. DIM has also been shown to 
activate AMPK signaling in ovarian cancer cells, and that this activation was required for 
induction of autophagy by DIM [26]. In our study, inhibition of AMPK expression using siRNA 
inhibited DIM- and ring-DIM-mediated conversion of LC3BI-to-LC3BII, indicating that the 
induction of autophagy by each of these compounds is dependent on AMPK activation (Fig 3). 
We found that the autophagy induced by DIM and ring-DIMs is cytoprotective in nature, since 
inhibition of either AMPK or ULK1 expression sensitized LNCaP and C42B cells, which 
underwent significant cell death in the presence of normally sub-toxic concentrations of DIM or 
ring-DIMs. The results confirm our earlier observations that pre-treatment of prostate cancer cells 
with the autophagy inhibitors bafilomycin A1 or 3-methyladenine also sensitized the cells to sub-
toxic concentrations of DIM and ring-DIMs, suggesting a protective role of the autophagic 
response to DIM and ring-DIMs [9]. Our pervious study showed a concentration-dependent 
induction of autophagy after a 24-h exposure to DIM or ring-DIMs [9]. Results in Figure 1 show 
that formation of autophagic vacuoles in LNCaP and C42B cells are observed after an 8-h 
exposure to DIM and ring-DIMs. In vivo studies to assess co-treatment of natural compound like 
DIM with autophagy inhibitors in various (prostate) cancer models would determine the potential 
to increase anticancer efficacy of such combined therapies. 
AEG-1 is overexpressed in various tumors including the prostate [20, 27] and contributes to 
chemoresistance in hepatocellular carcinoma (HCC) cells by increasing the expression of  multi-
drug resistance 1 (MDR1) gene [22], and knockdown of AEG-1 inhibits chemoresistance in 
cervical cancer cells [28]. Our present study reveals a novel mechanism of action for DIM- and 
ring-DIM-induced autophagy in human prostate cancer cells, which occurs via induction of AEG-













both LNCaP and C42B cells (Fig 4) and that the resultant induction of autophagy is dependent on 
AEG-1 (Fig 5). Inhibition of AEG-1 using siRNA repressed AMPK activation, indicating that 
AEG-1 is an upstream regulator of AMPK in prostate cancer cells. In line with our results, AEG-
1 has been previously shown to induce protective autophagy via activation of AMPK in response 
to cellular metabolic stress in immortalized primary human fetal astrocytes (IM-PHFA) and in a 
human malignant glioma cell line (T98G) [20, 21]. In addition, AEG-1 overexpression was found 
to enhance autophagy in malignant glioma cells undergoing TGFβ1-induced endothelial-
mesenchymal transition [27]. Kikuno and coworkers showed that downregulation of AEG-1 
induced apoptosis in LNCaP and PC3 prostate cancer cells through upregulation of FOXO3a 
activity [29]. As another example, the natural product cryptotanshinone (derived from Salvia 
miltiorrhiza) was found to exert antitumor activity via inhibition of AEG-1 in hypoxic AI PC-3 
prostate cancer cells [30]. Indeed, our current findings show that AEG-1 silencing sensitizes 
LNCaP and C42B cells to cell death mediated by sub-toxic concentrations of DIM and ring-
DIMs. Thus, the induction of AEG-1 would appear to be a cell protection mechanism against the 
cellular stress and cytotoxicity caused in response to DIM and ring-DIMs in prostate cancer cells.  
DIM targets multiple pathways associated with cancer progression in vitro and in vivo [31-33], 
and our findings provide further insight into the complexity of the mechanisms of anticancer 
action of DIM, as well as more potent synthetic DIM derivatives in prostate cancer cells. 
Charcoal-stripped serum (CSS) was used instead of fetal bovine serum (FBS) to minimize the 
level of androgens and other hormones to which the cells would be exposed [34]. The CSS 
culture medium of LNCaP cells was supplemented with 0.1 nM DHT to stimulate their androgen-
dependent growth in a defined manner. The AD LNCaP and AI C42B prostate cancer cells had 













treatment with DIM and ring-DIMs indicating a negligible effect of androgen signaling on the 
observed mechanisms. Interestingly we observed a protective effect after siRNA-mediated 
downregulation of AEG-1 against overtly cytotoxic concentrations of DIM or ring-DIMs in both 
LNCaP and C42B cells, which is contrast to our observed sensitization at subtoxic 
concentrations. Moreover, this protective effect of AEG-1 silencing was accompanied by 
induction of senescence in LNCaP and C42B cells treated with toxic concentration of DIM or 
ring-DIMs (Fig 6). Previous studies have shown that overexpression of AEG-1 inhibits 
senescence in hepatocytes isolated from transgenic mice by inhibiting the DNA damage response 
[23]. Senescent cells undergo irreversible proliferative arrest, which may inhibit tumor 
progression [30, 35, 36]. Accumulating evidence suggests that therapies directed at inducing 
senescence may improve cancer treatment outcomes [36-39]. Our study reveals that DIM- and 
ring-DIM-mediated induction of senescence and/or apoptosis is dependent on AEG-1, and 
induction of AEG-1 may be a key molecular switch that regulates the fate of prostate cancer cells 
either to undergo apoptosis or senescence (Fig 7). More studies are needed to assess the 
mechanism(s) of inhibition of senescence by AEG-1 and to determine the potential benefits of 
agents that induce senescence in treatment prostate cancer.  
5. CONCLUSION 
We have identified a novel mechanism of DIM- and ring-DIM-induced protective autophagy, 
which is clue to induction of AEG-1 and subsequent activation of AMPK. Our results suggest 
that development of novel drug therapies against prostate cancer could include selective 
autophagy inhibitors as adjuvants. Moreover, targeting DIM- and ring-DIM-mediated induction 
of AEG-1 and subsequent induction of senescence may be an effective novel therapy for treating 
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Figure 1: DIM, 4,4'-Br2DIM and 7,7'-Cl2DIM induce autophagic vacuole formation in 
LNCaP (A) and C42B (B) cells after an 8-h exposure. Autophagic vacuoles were detected 
using a Cyto-ID autophagy detection kit and nuclei were counterstained with Hoechst 33342 as 
described in Materials and Methods. LNCaP cells were treated with 20 µM DIM, 15µM 4,4'-
Br2DIM or 15 µM 7,7'-Cl2DIM, whereas C42B cells were treated with 30 µM DIM, 15µM 4,4'-
Br2DIM or 20µM 7,7'-Cl2DIM. Red arrows indicate representative examples of autophagic 
vacuoles stained with Cyto-ID. Scale bar = 50 µm. Fluorescence images are representative of 
three independent experiments. Number of autophagic vacuoles counted per cell in LNCaP (C) 
and C42B (D) cells are presented as means ± SEM of three independent experiments, each 
performed in triplicate. Statistically significant difference (*P<0.05, **P<0.01) were determined 
by one-way ANOVA and a Dunnett posthoc test to correct for multiple comparisons to control. 
Transmission electron microscopic images of C42B cells treated with DIM, 4,4'-Br2DIM or 7,7'-
Cl2DIM (E) for 8 h. Red arrows indicate autophagic vacuoles. Scale bar = 500 nm.  ER = 
endoplasmic reticulum, M = mitochondria, PM = plasma membrane, N = nucleus. 
 
Figure 2: DIM and ring-DIMs induce phosphorylation of AMPK, ACC, ULK1 and the 
conversion of LC3BI to II in LNCaP (A) and C42B (B) cells. LNCaP cells were exposed for 0, 
1, 4, 8 h to 30 µM DIM, 20µM 4,4'-Br2DIM or 20 µM 7,7'-Cl2DIM whereas C42B cells were 
0065posed to concentration s of  50 µM DIM, 20 µM 4,4'-Br2DIM or 30 µM 7,7'-Cl2DIM. Each 
gel is representative of three independent experiments. Percentage of intact LNCaP (C) and C42B 
(D) cells treated with DIM or ring-DIMs for 24 h with or without a 4-h pretreatment with ULK-1 
inhibitor MRT 67307. Percentages are presented as means ± SEM of three independent 













determined by one-way ANOVA and a Dunnett posthoc test to correct for multiple comparisons 
to control.  
 
Figure 3: DIM and ring-DIMs mediated autophagy is dependent on AMPK.  Levels of 
AMPK and LC3BI/II in LNCaP (A, C) and C42B (B, D) cells exposed to DIM, or ring-DIMs for 
24 h with or without a 24-h pretreatment with AMPK siRNA.  LNCaP and C42B cells were 
treated with 20 µM DIM, 15 µM 4,4'-Br2DIM or 15 µM 7,7'-Cl2DIM. Each gel is representative 
of three independent experiments. Percentage of intact LNCaP (E) and C42B (F) cells treated 
with DIM or ring-DIMs for 24 h with or without a 24-h pretreatment with AMPK siRNA. Results 
are representative of three independent experiments and shown as mean ± SEM. Statistically 
significant difference (*P<0.05, **P<0.01) were determined by one-way ANOVA and a Dunnett 
posthoc test to correct for multiple comparisons to control.  
 
Figure 4: DIM and ring-DIMs induce AEG-1 in LNCaP and C42B cells. AEG-1 and 
LC3BI/II levels in LNCaP (A, C) and C42B (B, D) cells treated for 24 h with DIM, 4,4'-Br2DIM 
or 7,7'-Cl2DIM. LNCaP cells were treated with 30 µM DIM, 20µM 4,4'-Br2DIM or 20µM 7,7'-
Cl2DIM, whereas C42B cells were treated with 50 µM DIM, 20µM 4,4'-Br2DIM or 30µM 7,7'-
Cl2DIM. Statistically significant difference (*P<0.05, **P<0.01) were determined by one-way 
ANOVA and a Dunnett posthoc test to correct for multiple comparisons to control.  
 
  
Figure 5: DIM- and ring-DIM-mediated autophagy is dependent on AEG-1. Levels of AEG-
1, phospho-ACC, and LC3BI/II in LNCaP (A, C) and C42B (B, D) cells exposed to DIM, 4,4'-













LNCaP and C42B cells were treated with 20 µM DIM, 15 µM 4,4'-Br2DIM or 15 µM 7,7'-
Cl2DIM. Each gel is representative of three independent experiments. Percentage of intact 
LNCaP (E) and C42B (F) cells after a 24-h exposure to DIM, 4,4'-Br2DIM or 7,7'-Cl2DIM with 
or without a 24-h pretreatment with AEG-1 siRNA. Percentages are presented as means ± SEM 
of three independent experiments. Statistically significant difference (*P<0.05, **P<0.01) were 
determined by one-way ANOVA and a Dunnett posthoc test to correct for multiple comparisons 
to control.  
 
Figure 6: Percentage of intact LNCaP (A) and C42B (B) cells exposed to DIM, 4,4'-Br2DIM or 
7,7'-Cl2DIM for 24 h with or without a 24-h pretreatment with AEG-1 siRNA. Senescence in 
LNCaP (C) and C42B (D) cells after a 24 h exposure to DIM, 4,4'-Br2DIM and 7,7'-Cl2DIM with 
or without a 24 h pretreatment with AEG-1 siRNA. LNCaP cells were treated with 20 µM DIM, 
15 µM 4,4'-Br2DIM or 15 µM 7,7'-Cl2DIM, whereas C42B cells were treated with 30 µM DIM, 
15 µM 4,4'-Br2DIM or 20 µM 7,7'-Cl2DIM. Senescence was measured using a senescence β-
galactosidase staining kit as described in materials and methods. Images are representative of 
three independent experiments. Scale bar = 50 µm.  Percentage of β-galactosidase-positive 
LNCaP (E) and C42B (F) cells treated as described above. Percentages are presented as means ± 
SEM of three independent experiments. Statistically significant difference (*P<0.05, ** P<0.01, 
***P<0.001) were determined by one-way ANOVA and a Dunnett posthoc test to correct for 
multiple comparisons to control.  
.  
Figure 7: A schematic representation of the proposed mechanism of DIM-, 4,4'-Br2DIM- and 














Figure S1: Cell proliferation of LNCaP (A) and C42B (B) cells exposed to DIM with or without 
a 24-h pretreatment with AEG-1 siRNA. 
Figure S2: Protein levels of pAMPK, pACC, ULK1, LC3BI and LC3BII (expressed as LC3BII/I 
ratio) in LNCaP cells after a 0, 1, 4, 8 h of exposure to DIM, 4,4'-Br2DIM or 7,7'-Cl2DIM. 
Quantification of protein bands densitometry was carried out using ImageJ 1.6 software (Wayne 
Rasband, NIH) 
Figure S3: Protein levels of pAMPK, pACC, ULK1 LC3BI and LC3BII (expressed as LC3BII/I 
ratio) in C42B cells after 0, 1, 4, 8 h of exposure to DIM, 4,4'-Br2DIM or 7,7'-Cl2DIM. 


























































































































(1) DIM and ring-DIMs induce the formation of autophagic vacuoles in prostate cancer cells.  
(2) Inhibition of either AEG-1 or AMPK expression sensitizes prostate cancer cells, which underwent 
significant cell death in the presence of normally sub-toxic concentrations of DIM or ring-DIMs.  
(3) DIM- and ring-DIM-induced protective autophagy is mediated through the induction of the oncogenic 
protein AEG-1 and subsequent activation of AMPK.  
(4) Downregulation of AEG-1 induces senescence in prostate cancer cells. 
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